Molecure S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
For the nine months, sales was PLN 1.47 million compared to PLN 0.658196 million a year ago. Net loss was PLN 9.36 million compared to PLN 6.83 million a year ago. Basic loss per share from continuing operations was PLN 0.67 compared to PLN 0.49 a year ago. Diluted loss per share from continuing operations was PLN 0.67 compared to PLN 0.49 a year ago.